There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
To report the short-term safety, biologic effect, and a possible mechanism of action
of intravitreal bevacizumab in patients with neovascular age-related macular degeneration
(AMD).